Skip to main content
OpenTrials
Completed

NCT Number: NCT01709825

The Effect of Probiotics (L. Helveticus, B. Longum, and B. Bifidum) on Immune Function and Digestive Health

The purpose of this study is to determine if daily consumption of a probiotic in the period before, during and after academic exams will help maintain digestive and immune health and quality of life of undergraduate students.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Florida

Gainesville, Florida, 32611, United States

About this study

A randomized, double-blinded, placebo-controlled trial will be used. Healthy full-time undergraduate students will be recruited from the University of Florida via flyers, emails, announcements, etc. Informed consent will be obtained and the inclusion/exclusion criteria will be reviewed to determine whether a participant qualifies for the study. All participants will be consented for the main six-week intervention and a subgroup (n=50/group) of these students will be consented to provide two stool samples.

Participants will provide saliva and stool samples (for the sub-group)during the pre-baseline week and during the week of final exams at approximately week 4. At the randomization visit, height, weight and age will be obtained. Participants will be stratified based on body mass index and randomized via sealed envelopes to one of four groups: Lactobacillus helveticus, Bifidobacterium longum ssp. Infantis, Bifidobacterium bifidum or the placebo (n=145/group). Participants will take the study provided capsule of probiotic or placebo daily for 6 weeks. Participants will receive daily questionnaires via email throughout the prebaseline week and the 6-week intervention. Daily questionnaires will ask about intake of the supplement, cold symptoms, and general health (i.e., new medications, doctor visits). Throughout the study, participants will also be asked to complete weekly questionnaires (inquiring about gastrointestinal symptoms and physical activity) and Quality of Life Questionnaires (administered during pre-baseline, final exam week and week 6 of the study).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

To participate in the study you must:

  • be 18 years of age or older.
  • be a healthy full-time undergraduate at the University of Florida.
  • be willing to complete daily questionnaires form via computer.
  • be willing to discontinue any immune-enhancing dietary supplements (e.g., prebiotics and fiber supplements, probiotics, echinacea, fish oil, vitamin E >400% of the RDA or >60 mg/day).
  • be willing to take the probiotic capsule daily of 6 weeks.
  • have had at least one cold in the last 12 months.
  • have at least 1 final during the scheduled exam week.
  • have daily access to the Internet.

Exclusion criteria

To participate in the study you must NOT:

  • be a current smoker.
  • have chronic allergies involving the upper respiratory tract.
  • have had immunosuppressive illness or treatment within the last year.
  • have received antibiotic therapy in the past two months.

Treatment and study plan

Probiotic- Bifidobacterium Bifidum

Dietary Supplement

Bifidobacterium bifidum R0071 will be taken as a capsule once daily for 6 weeks.

Other names: Bifidobacterium bifidum, Supplement A

Sugar Pill

Dietary Supplement

Sugar Pill (Sucrose) will be taken as a capsule once daily for 6 weeks.

Other names: Sucrose

Probiotic- Lactobacillus helveticus

Dietary Supplement

Lactobacillus helveticus R0052 will be taken as a capsule once daily for 6 weeks.

Other names: Lactobacillus helveticus, Supplement B

Probiotic- Bifidobacterium longum ss. Infantis R0033

Dietary Supplement

Bifidobacterium longum ss. Infantis R0033 (Supplement C) will be taken as a capsule once daily for 6 weeks.

Other names: Bifidobacterium longum ss. Infantis R0033, Supplement C

Primary outcomes

  1. Proportion of days without cold/flu

    Time frame: over 6 weeks

    The intensity of cold/flu symptoms (running/congested nose, stiffness or chills, headache, cough, fatigue, fever, sore throat, achiness, and ear discomfort)will be scored as 0 (not experiencing) to 3 (severe). The symptom intensity from the 9 cold/flu symptoms will be summed to obtain a symptom intensity score. A symptom intensity score of >6 will be designated as a day of cold. The mean proportion of days without a cold/flu will be compared between each probiotic and the placebo.

  2. Microbiota Study

    Time frame: Change in microbiota from pre-baseline to on average week 4

    • Microbial diversity measured by DGGE profiling (detect large distortions)
    • qPCR to quantify treatment effects on specific bacteria
  3. Digestive Health

    Time frame: Daily for 7 weeks

    • Gastrointestinal symptoms (gas, bloating, diarrhea, etc.)
    • Bowel habits (bowel movement frequency and consistency)
    • Measures of quality of life (physical functioning, general health, bodily pain, vitality and social functioning)

Secondary outcomes

  1. Immune Health

    Time frame: Measured at pre-baseline and on average week 4

    • Salivary secretory immunoglobulin A (sIgA)
    • Fecal sIgA

Sponsors and collaborators

Lead sponsor

University of Florida

Other

Collaborators

  • Lallemand Human Nutrition

Registry information

Official study title

The Effect of Probiotics on Immune Function, and Digestive Health in Academically-stressed University Students: A Randomized, Double-blinded, Placebo-controlled Study

Important dates

Study start
2012
Primary completion
2012
Study completion
2013
First posted
Oct 18, 2012
Registry last updated
Jan 29, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.